Market Estimates
Valuation Metrics
Financials
Trading Trends
NVO News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Novo Nordisk A/S (NVO) stock price today?
The current price of NVO is 56.57 USD — it has increased 0.55 % in the last trading day.
What is Novo Nordisk A/S (NVO)'s business?
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
What is the price predicton of NVO Stock?
Wall Street analysts forecast NVO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVO is 57.37 USD with a low forecast of 47.00 USD and a high forecast of 70.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Novo Nordisk A/S (NVO)'s revenue for the last quarter?
Novo Nordisk A/S revenue for the last quarter amounts to 11.74B USD, increased 11.81 % YoY.
What is Novo Nordisk A/S (NVO)'s earnings per share (EPS) for the last quarter?
Novo Nordisk A/S. EPS for the last quarter amounts to 0.70 USD, decreased -22.22 % YoY.
What changes have occurred in the market's expectations for Novo Nordisk A/S (NVO)'s fundamentals?
How many employees does Novo Nordisk A/S (NVO). have?
Novo Nordisk A/S (NVO) has 76302 emplpoyees as of January 08 2026.
What is Novo Nordisk A/S (NVO) market cap?
Today NVO has the market capitalization of 251.21B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260106170342_7ae8fad7dc650dbc6701ab80ff0e2788.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108190337_e5c33cbb7003ed7fa518fac071a2ad2e.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260107205138_a182ce642513e5b221d95649890cbc18.jpg&w=384&q=75)